parthenolide has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaspole, I; Jaffar, J; Symons, K; Westall, G | 1 |
1 other study(ies) available for parthenolide and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Cell Survival; Dose-Response Relationship, Drug; Female; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; NF-kappa B; Sesquiterpenes | 2021 |